- Home
- RCMT vs ORMP Comparison
RCMT vs ORMP Comparison
Compare RCMT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCMT | ORMP |
|---|---|---|
| Founded | 1971 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 200.2M | 165.3M |
| IPO Year | 1997 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RCMT | ORMP |
|---|---|---|
| Price | $28.85 | $4.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 69.1K | ★ 470.5K |
| Earning Date | 04-03-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 27.38 | ★ 412.50 |
| EPS | 0.52 | ★ 0.91 |
| Revenue | ★ $186,737,000.00 | $2,000,000.00 |
| Revenue This Year | $11.89 | N/A |
| Revenue Next Year | $12.46 | N/A |
| P/E Ratio | $54.81 | ★ $5.05 |
| Revenue Growth | 5.83 | ★ 49.25 |
| 52 Week Low | $17.26 | $1.98 |
| 52 Week High | $32.50 | $5.19 |
Technical Indicators
Market Signals| Indicator | RCMT | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 65.71 | 60.43 |
| Support Level | $17.77 | $3.69 |
| Resistance Level | $32.39 | $5.10 |
| Average True Range (ATR) | 1.21 | 0.32 |
| MACD | 0.32 | 0.08 |
| Stochastic Oscillator | 81.64 | 58.74 |
Price Performance
Historical ComparisonAbout RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.